• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Streck Cell-Free DNA BCT Receives FDA De Novo Clearance americanpharmaceuticalreview
    September 18, 2020
    Streck Cell-Free DNA BCT received U.S. Food and Drug Administration (FDA) De Novo clearance for In Vitro Diagnostic use when paired with the Guardant360 CDx liquid biopsy assay.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service